Frequent Infection of Cats With SARS-CoV-2 Irrespective of Pre-Existing Enzootic Coronavirus Immunity, Brazil 2020.

Frequent Infection of Cats With SARS-CoV-2 Irrespective of Pre-Existing Enzootic Coronavirus Immunity, Brazil 2020.
复制标题

DOI:
10.3389/fimmu.2022.857322
复制
发表时间:
2022
影响因子:
7.3
通讯作者:
--
中科院分区:
医学2区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

猫和水貂等食肉动物对SARS-CoV-2高度敏感。巴西是全球COVID-19热点地区,已记录了几例人猫传播病例。我们通过测试2020年7月至11月期间从巴西南部,东南部和东北部的七个州抽样的547只家猫来调查SARS-CoV-2的传播。此外,我们研究了地方性冠状病毒引起的免疫反应是否会影响猫的SARS-CoV-2感染。我们发现,与早期SARS-CoV-2 B.1分离株相比,2020年巴西流行的关注γ变体的中和抗体滴度显著更高(p<0.0001),验证了使用γ进行进一步测试。通过空斑减少中和试验(PRNT 90)验证,2020年底巴西猫的总体SARS-CoV-2血清阳性率为7.3%(95%CI,5.3-9.8)。巴西各州猫的SARS-CoV-2血清阳性率无显著差异,表明感染水平均匀,范围为4.6%(95%CI,2.2-8.4)至11.4%(95%CI,6.7-17.4; p=0.4438)。PRNT 90中原型猫冠状病毒猫冠状病毒(FCoV)的血清阳性率高达33.3%(95% CI,24.9-42.5),PRNT 90中牛冠状病毒(BCoV)的血清阳性率低至1.7%(95% CI,0.2-5.9)。FCoV的中和抗体滴度显著低于SARS-CoV-2(p=0.0001),这与猫最近感染SARS-CoV-2的情况一致。SARS-CoV-2抗体滴度的大小(p=0.6390)和SARS-CoV-2感染状态均不受FCoV血清状态的影响(p=0.8863)。我们的数据表明,预先存在的对地方性冠状病毒的免疫力既不能预防,也不能增强猫的SARS-CoV-2感染。在大流行的第一年,SARS-CoV-2血清阳性率已经很高,这证实了家猫的频繁感染,并引起了人们对潜在的SARS-CoV-2突变的担忧,这些突变在溢出时会逃避人类免疫力。
Carnivores such as cats and minks are highly susceptible to SARS-CoV-2. Brazil is a global COVID-19 hot spot and several cases of human-to-cat transmission have been documented. We investigated the spread of SARS-CoV-2 by testing 547 domestic cats sampled between July-November 2020 from seven states in southern, southeastern, and northeastern Brazil. Moreover, we investigated whether immune responses elicited by enzootic coronaviruses affect SARS-CoV-2 infection in cats. We found infection with significantly higher neutralizing antibody titers against the Gamma variant of concern, endemic in Brazil during 2020, than against an early SARS-CoV-2 B.1 isolate (p<0.0001), validating the use of Gamma for further testing. The overall SARS-CoV-2 seroprevalence in Brazilian cats during late 2020 validated by plaque reduction neutralization test (PRNT90) was 7.3% (95% CI, 5.3-9.8). There was no significant difference in SARS-CoV-2 seroprevalence in cats between Brazilian states, suggesting homogeneous infection levels ranging from 4.6% (95% CI, 2.2-8.4) to 11.4% (95% CI, 6.7-17.4; p=0.4438). Seroprevalence of the prototypic cat coronavirus Feline coronavirus (FCoV) in a PRNT90 was high at 33.3% (95% CI, 24.9-42.5) and seroprevalence of Bovine coronavirus (BCoV) was low at 1.7% (95% CI, 0.2-5.9) in a PRNT90. Neutralizing antibody titers were significantly lower for FCoV than for SARS-CoV-2 (p=0.0001), consistent with relatively more recent infection of cats with SARS-CoV-2. Neither the magnitude of SARS-CoV-2 antibody titers (p=0.6390), nor SARS-CoV-2 infection status were affected by FCoV serostatus (p=0.8863). Our data suggest that pre-existing immunity against enzootic coronaviruses neither prevents, nor enhances SARS-CoV-2 infection in cats. High SARS-CoV-2 seroprevalence already during the first year of the pandemic substantiates frequent infection of domestic cats and raises concerns on potential SARS-CoV-2 mutations escaping human immunity upon spillback.
DOI: 10.1016/j.vaccine.2008.10.087
发表时间: 2009-01-22
期刊: Vaccine
影响因子: 5.5
作者:
Huisman W;Martina BE;Rimmelzwaan GF;Gruters RA;Osterhaus AD
通讯作者: Osterhaus AD
SARS-COV-2在人类和貂皮之间的貂皮农场上传播,然后回到人类。
DOI: 10.1126/science.abe5901
发表时间: 2021-01-08
期刊: Science (New York, N.Y.)
影响因子: --
作者:
Oude Munnink BB;Sikkema RS;Nieuwenhuijse DF;Molenaar RJ;Munger E;Molenkamp R;van der Spek A;Tolsma P;Rietveld A;Brouwer M;Bouwmeester-Vincken N;Harders F;Hakze-van der Honing R;Wegdam-Blans MCA;Bouwstra RJ;GeurtsvanKessel C;van der Eijk AA;Velkers FC;Smit LAM;Stegeman A;van der Poel WHM;Koopmans MPG
通讯作者: Koopmans MPG
DOI: 10.1016/j.jfms.2009.05.008
发表时间: 2009-07
影响因子: 1.7
作者:
Addie D;Belák S;Boucraut-Baralon C;Egberink H;Frymus T;Gruffydd-Jones T;Hartmann K;Hosie MJ;Lloret A;Lutz H;Marsilio F;Pennisi MG;Radford AD;Thiry E;Truyen U;Horzinek MC
通讯作者: Horzinek MC
DOI: 10.3201/eid2612.202223
发表时间: 2020-12
影响因子: 11.8
作者:
Garigliany M;Van Laere AS;Clercx C;Giet D;Escriou N;Huon C;van der Werf S;Eloit M;Desmecht D
通讯作者: Desmecht D
DOI: 10.3390/vaccines8040772
发表时间: 2020-12-17
期刊: Vaccines
影响因子: 7.8
作者:
Michelitsch A;Hoffmann D;Wernike K;Beer M
通讯作者: Beer M